Holen Sie sich die Stockscreener-App
1.79
0.56%
-0.01
Handel nachbörslich:
1.79
Schlusskurs vom Vortag:
$1.80
Offen:
$1.81
24-Stunden-Volumen:
3,115
Relative Volume:
0.10
Marktkapitalisierung:
$29.78M
Einnahmen:
$48.43M
Nettoeinkommen (Verlust:
$-11.04M
KGV:
-3.7292
EPS:
-0.48
Netto-Cashflow:
$-7.00M
1W Leistung:
-0.56%
1M Leistung:
+11.18%
6M Leistung:
-26.03%
1J Leistung:
-29.80%
1-Tages-Spanne:
$1.7706
$1.81
1-Wochen-Bereich:
$1.73
$1.86
52-Wochen-Spanne:
$1.2717
$3.65
Iridex Corp Stock (IRIX) Company Profile
Firmenname
Iridex Corp
Sektor
Branche
Telefon
(650) 940-4700
Adresse
1212 TERRA BELLA AVE, MOUNTAIN VIEW, CA
Vergleichen Sie IRIX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRIX
Iridex Corp
|
1.79 | 29.78M | 48.43M | -11.04M | -7.00M | -0.67 |
|
ABT
Abbott Laboratories
|
118.77 | 206.00B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
392.15 | 149.49B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
90.66 | 133.62B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
86.54 | 110.97B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
71.35 | 42.08B | 6.60B | 4.16B | 490.10M | 6.93 |
Iridex Corp Stock (IRIX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2017-11-03 | Fortgesetzt | ROTH Capital | Buy |
| 2016-12-21 | Eingeleitet | ROTH Capital | Buy |
| 2016-01-26 | Eingeleitet | Singular Research | Buy |
| 2007-01-03 | Eingeleitet | First Albany | Buy |
Iridex Corp Aktie (IRIX) Neueste Nachrichten
Advancing Healthcare Tech: Medical Lasers Market Report 2024 - WhaTech
IRIDEX Corporation (NASDAQ:IRIX) Q3 2024 Earnings Call Transcript - MSN
Iridex's Glaucoma Treatment Exempt from New Medicare Reimbursement Limits | IRIX Stock News - StockTitan
IRIDEX Corp adjusts executive compensation, reshuffles board By Investing.com - Investing.com Australia
IRIDEX Corp adjusts executive compensation, reshuffles board - Investing.com India
IRIDEX earnings missed by $0.03, revenue fell short of estimates - Investing.com Australia
IRIDEX Corp (IRIX) Q3 2024 Earnings Call Highlights: Strategic Moves and Glaucoma Growth Amid ... - Yahoo Finance
Iridex: Q3 Earnings Snapshot - The Washington Post
Iridex Q3 Revenue Falls 10% YoY, Aims for Q4 EBITDA Breakeven Amid Strategic Review | IRIX Stock News - StockTitan
Iridex Reports Third Quarter 2024 Financial Results - Yahoo Finance
StockNews.com Begins Coverage on IRIDEX (NASDAQ:IRIX) - Defense World
IRIDEX (NASDAQ:IRIX) Coverage Initiated by Analysts at StockNews.com - Defense World
Iridex to Report Third Quarter 2024 Financial Results on November 12, 2024 - StockTitan
IRIX Stock Sees Significant Drop Amid Market Fluctuation - GuruFocus.com
IRIDEX Co. (NASDAQ:IRIX) Short Interest Up 9.9% in October - Defense World
IRIDEX (NASDAQ:IRIX) Earns Hold Rating from Analysts at StockNews.com - Defense World
Ophthalmic Photocoagulator Market to Witness Huge Growth by 2032 |Alcon, NIDEK, IRIDEX, Lumenis Be - openPR
IRIDEX (NASDAQ:IRIX) Research Coverage Started at StockNews.com - Defense World
Ophthalmology Devices Market projected to grow by USD 19.1 Billion from 2024-2028, driven by AI-powered innovations and rising prevalence of ophthalmic diseasesTechnavio - The Malaysian Reserve
IRIDEX Corp (IRIX) Q2 2024 Earnings Call Highlights: Navigating Growth and Challenges - Yahoo Finance
IRIX stock touches 52-week low at $1.62 amid market challenges By Investing.com - Investing.com South Africa
IRIX stock touches 52-week low at $1.62 amid market challenges - Investing.com Australia
Iridex names Patrick Mercer as new CEO to drive strategic review - Investing.com
Iridex Appoints Patrick Mercer as Chief Executive Officer - StockTitan
Medical Laser Market Size, Share, Growth and Industry Trends – news - North America Agile Program ...
Medical Laser Technology Market Size, Share, Trends & Forecast - Third Eye News
IRIDEX (NASDAQ:IRIX) Now Covered by StockNews.com - Defense World
Medical Lasers Market 2024: Exploring Industry Demand, Technological Advancements, And Future Prospects - WhaTech
Global Diabetes Associated Ophthalmic Treatment Market Size To Exceed USD 56.43 Billion By 2033 l CAGR Of 6.61% - India Shorts
Iridex (NASDAQ:IRIX) Stock Quotes, Forecast and News Summary - Benzinga
Iridex Frustrates, But Expect A Transaction By Year-End (NASDAQ:IRIX) - Seeking Alpha
Iridex finds accounting error, Q1 loss to widen by 1 cent/shr - Reuters
IRIDEX Corporation (NASDAQ:IRIX) Q2 2024 Earnings Call Transcript - Insider Monkey
StockNews.com Initiates Coverage on IRIDEX (NASDAQ:IRIX) - Defense World
Earnings call: IRIDEX sees growth in Q2 with strategic review underway - Investing.com Canada
Iridex revenue drops to USD 12.6M in Q2 2024 - Medical Buyer
IRIDEX Corporation (IRIX) Q2 2024 Earnings Call Transcript - Seeking Alpha
Iridex: Q2 Earnings Snapshot - Houston Chronicle
Iridex Reports Second Quarter 2024 Financial Results - Yahoo Finance
Iridex announces convertible note financing - Medical Buyer
Iridex secures $3.5 million in private placement financing - Investing.com
IRIDEX (NASDAQ:IRIX) Now Covered by Analysts at StockNews.com - Defense World
Iridex Announces Convertible Note Financing - Yahoo Finance
IRIDEX (IRIX) Set to Announce Earnings on Thursday - Defense World
Energy-Based Aesthetic Devices Market size is set to grow by USD 2.13 billion from 2024-2028, Increasing demand for aesthetic procedures boost the market, Technavio - The Malaysian Reserve
Finanzdaten der Iridex Corp-Aktie (IRIX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.73%
0.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):